Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effect of vırtual realıty on paın and Sleep qualıty ın Women

3 de junio de 2026 actualizado por: Remzi KARASUNGUR, Hasan Kalyoncu University

The Effect of vıdeo Watched wıth musıc Through vırtual realıty Glasses and musıc lıstenıng Alone on paın and Sleep qualıty ın Women wıth Dysmenorrhea

The aim of this study is to determine whether a video viewed through virtual reality goggles accompanied by music has an effect on pain and sleep quality in women with dysmenorrhea. The main questions it seeks to answer are as follows:

  • Does watching a video through virtual reality goggles accompanied by music reduce pain in women with dysmenorrhea?
  • Does watching a video through virtual reality goggles accompanied by music improve sleep quality in women with dysmenorrhea? The study will compare a group that uses music from the virtual reality video with another group to determine whether the virtual reality application has an effect on pain and sleep quality.

Participants will do the following:

For 3 days, use the virtual reality or music application every evening before going to bed after completing the VAS. The next day, after waking up, complete the VAS and the sleep quality scale and record the results.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

77

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Women who volunteered to participate in the study,
  • Who are at least literate,
  • Aged 15-49 and not yet in menopause,
  • Who are not pregnant,
  • Who have been diagnosed with dysmenorrhea by a physician and have a pain intensity of at least 4 on the Visual Analogue Scale

Exclusion Criteria:

  • Women with dysmenorrhea pain intensity below 4 on the Visual Analog Scale,
  • Women with vision or hearing impairments,
  • Women who are unwilling to participate in the study,
  • Women using analgesic medications for menstrual pain,
  • Pregnant women

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Cuadruplicar

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: experiment
Group shown a video using a virtual reality headset: For this experiment, a video featuring nature scenes and waterfalls was downloaded to a phone, loaded into a virtual reality headset, and provided to the participant ready for use.

Group shown a video using a virtual reality headset: A video containing images of nature and waterfalls is downloaded to a phone and provided to the participant ready to use inside a virtual reality headset; the procedure is carried out as described below.

For three consecutive days, each day:

  • After menstruation begins, apply the VAS pain scale before going to bed in the evening
  • In the evening, in a dark and quiet environment, watch the 30-minute virtual reality video as instructed by the researcher until falling asleep
  • The following morning, apply the VAS pain scale and RCUÖ and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Otros nombres:
  • Realidad virtual
Comparador de placebos: control
Unlike the intervention group, the women in the control group were given MP3 players by the researcher, instructed on how to use them, and had the music used in the virtual reality video loaded onto the devices for them to listen to.

Unlike the intervention group, the women in the control group were given an MP3 player by the researcher, instructed on how to use it, and had the music used in the virtual reality video loaded onto it for them to listen to.

For three consecutive days, each day:

  • Apply the VAS pain scale in the evening before going to bed after menstruation has occurred
  • Listen to the 30-minute music in a dark and quiet environment in the evening, as instructed by the researcher
  • Apply the VAS pain scale and RCUÖ the following morning and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Otros nombres:
  • música

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Distribution of women according to the characteristics of their menstrual cycles
Periodo de tiempo: 4 weeks
This table includes the latest menstrual pain scale, the occurrence of pain during the menstrual cycle, the type of dysmenorrhea, the timing of dysmenorrhea, information about menstruation, who provided information about menstruation, the use of pain relievers during the menstrual period, non-pharmacological interventions used to alleviate menstrual pain, non-pharmacological interventions used to alleviate menstrual pain, the presence of dysmenorrhea in the family, and gynecological diagnosis data. Patients with a pain scale (VAS) score of 4 or higher were evaluated, and the analysis proceeded to secondary outcomes.
4 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Comparison of Participants' Sociodemographic Characteristics by Group
Periodo de tiempo: 2 weeks
This table presents sociodemographic data such as women's marital status, age, and chronic conditions.
2 weeks
A Comparison of Certain Characteristics of Participants' Menstrual Cycles Across Groups
Periodo de tiempo: 4 weeks
This table presents data such as the age at first menstruation, menstrual cycle length, and duration of menstrual bleeding
4 weeks
Comparison of Dysmenorrhea Characteristics Among Participants by Group
Periodo de tiempo: 4 weeks
This table examines data such as the onset of dysmenorrhea, the presence of dysmenorrhea in the family, the family history of dysmenorrhea, the severity of pain during menstruation, and the use of pain relievers during menstruation.
4 weeks
Comparison of Participants' Sleep-Related Characteristics by Group
Periodo de tiempo: 4 weeks
This table provides information on a woman's sleep patterns during her menstrual cycle
4 weeks
Comparisons of Participants' Visual Analog Scale (VAS) Scores Between and Within Groups
Periodo de tiempo: 6 weeks

A visual analog scale is a pain assessment tool where individuals mark their pain level on a horizontal bar ranging from 0 to 10. The starting point of the scale indicates the absence of pain, while the end point indicates that the pain is unbearable.

This table shows the woman's pain scale assessment.

6 weeks
Comparisons of Participants' Richard Campbell Sleep Scale (RCSQ) Scores Across and Within Groups
Periodo de tiempo: 6 weeks
The Richard Campbell Sleep Scale assesses the depth of sleep, the time it takes to fall asleep, the frequency of waking, the duration of wakefulness upon waking, the quality of sleep, and the noise level in the environment. Each item on the scale is scored on a scale of 0 to 100. A score of "0-25" indicates "very poor sleep," while a score of "76-100" indicates "very good sleep." When calculating the total scale score, the scores from the 5 items are added together; the noise level in the environment is not included in the total score calculation.
6 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: Remzi KARASUNGUR, not affiliated

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

5 de enero de 2023

Finalización primaria (Actual)

29 de marzo de 2023

Finalización del estudio (Actual)

24 de septiembre de 2023

Fechas de registro del estudio

Enviado por primera vez

7 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

3 de junio de 2026

Publicado por primera vez (Actual)

8 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

8 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

3 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

When our study is published as an article, the data on the individuals will be presented to researchers in tabular

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir